Shenzhen Kangtai Biological Products: Announcement regarding not adjusting the Kangtai Conversion 2 stock price downwards.
Kangtai Biotech: Announcement on not revising the “Kangtai Transfer 2” stock conversion price downward
Kangtai Biotech: Notice on holding Kangtai's first bond holders' meeting in 2023
Kangtai Biotech: Announcement on the results of the resale of “Kangtai Transfer 2”
Kangtai Biotech: Third indicative announcement on the resale of “Kangtai Transfer 2”
Kangtai Biotech: Second indicative announcement on the resale of “Kangtai Transfer 2”
Kangtai Biotech: First indicative announcement on the resale of “Kangtai Transfer 2”
Kangtai Biotech: Second Interim Management Report on the Issuance of Convertible Corporate Bonds by Shenzhen Kangtai Biological Products Co., Ltd. to unspecified targets (2022)
Kangtai Biotech: Report on temporary fiduciary management affairs of Shenzhen Kangtai Biological Products Co., Ltd. issuing convertible corporate bonds to unspecified targets
Kangtai Biotech: Notice on holding the “Kangtai Transfer 2” first bond holders' meeting in 2022
Kangtai Biotech: Announcement on interest payments on convertible corporate bonds in 2022
Kangtai Biotech: 2021 Annual Equity Distribution Implementation Notice
Kangtai Biotech: Report on the fiduciary management affairs of Shenzhen Kangtai Biological Products Co., Ltd. issuing convertible corporate bonds to unspecified targets (2021)
Kangtai Biotech: A letter of sponsorship issued by Shenzhen Kangtai Biological Products Co., Ltd. issued convertible corporate bonds to unspecified targets and listed on the GEM
Kangtai Biotech: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Kangtai Biotech: Prospectus Notice for Issuance of Convertible Corporate Bonds to Unspecified Targets
Kangtai Biotech: An Empirical Analysis Report on Issuance of Convertible Corporate Bonds to Unspecified Targets
Kangtai Biotech: 1-1 Application Instructions (Application Draft)
Kangtai Biotech: 2 accounting firms respond to comments
Kangtai Biotech: 1 of the 3 Supplemental Legal Opinions
No Data